TNSN06057A1 - Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent - Google Patents

Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Info

Publication number
TNSN06057A1
TNSN06057A1 TNP2006000057A TNSN06057A TNSN06057A1 TN SN06057 A1 TNSN06057 A1 TN SN06057A1 TN P2006000057 A TNP2006000057 A TN P2006000057A TN SN06057 A TNSN06057 A TN SN06057A TN SN06057 A1 TNSN06057 A1 TN SN06057A1
Authority
TN
Tunisia
Prior art keywords
ivabradine
chlorhydrate
contiennent
qui
preparation
Prior art date
Application number
TNP2006000057A
Other languages
French (fr)
Inventor
Horvath Stephane
Auguste Marie-Noelle
Damen Gerard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Priority to TNP2006000057A priority Critical patent/TNSN06057A1/en
Publication of TNSN06057A1 publication Critical patent/TNSN06057A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORME CRISTALLINE DU CHLORHYDRATE DE L'IVABRADINE DE FORMULE (1) : CARACTERISEE PAR SON DIAGRAMME DE DIFFRACTION X SUR POUDRE. MEDICAMENTS.
TNP2006000057A 2006-02-15 2006-02-15 Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent TNSN06057A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TNP2006000057A TNSN06057A1 (en) 2006-02-15 2006-02-15 Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP2006000057A TNSN06057A1 (en) 2006-02-15 2006-02-15 Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
TNSN06057A1 true TNSN06057A1 (en) 2007-10-03

Family

ID=58669362

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000057A TNSN06057A1 (en) 2006-02-15 2006-02-15 Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Country Status (1)

Country Link
TN (1) TNSN06057A1 (en)

Similar Documents

Publication Publication Date Title
MA28133A1 (en) CRYSTALLINE FORM IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28132A1 (en) GAMMAD CRYSTALLINE FORM IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
MA28134A1 (en) CRYSTALLINE GAMMA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
MA28450B1 (en) NOVEL IV CRYSTALLINE FORM OF AGOMELATIN, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
CA2508824A1 (en) Alpha crystalline form of strontium ranelate, its preparation process, and the pharmaceutical compositions that contain it
FR2891827B1 (en) CRYSTALLINE DELTAD FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2891826B1 (en) CRYSTALLINE FORM 6 OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28449B1 (en) NOVEL CRYSTALLINE FORM III OF AGOMELATIN, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL189008A (en) 1-naphthalenyl-3-azabicyclo[3.1.0]hexane derivatives, process for their preparation and pharmaceutical compositions comprising them
FR2882553B1 (en) CRYSTALLINE BETA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28451B1 (en) NOVEL CRYSTALLINE FORM V OF AGOMELATIN, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUE037069T2 (en) Process for the preparation of highly pure 2,4'-methylenediphenyldiisocyanate
MX2007004294A (en) Pharmaceutical compositions comprising levetiracetam and process for their preparation.
EP2052043A4 (en) Process for preparation of silver nanoparticles, and the compositions of silver ink containing the same
PL1924561T3 (en) 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
TW200738283A (en) Formulations of conjugated estrogens and bazedoxifene
MA30276B1 (en) ALPHA CRYSTALLINE FORM OF PERINOPRIL ARGININE SALT, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL181691A0 (en) Method for the preparation of 2'-deoxy-2',2'-difluorocytidine
SI1589014T1 (en) Process for the preparation of 1,3-dihydro-2H-3-benzazepin-2-one and application to the preparation of ivabradine and their pharmaceutically acceptable salts
MX2008001012A (en) Oral care products.
TNSN06056A1 (en) Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
TNSN06057A1 (en) Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
TNSN06054A1 (en) Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
TNSN06055A1 (en) Forme cristalline du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
ZA200501010B (en) BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.